L-β,γ-Me-ATP
Overview[edit | edit source]
L-β,γ-Me-ATP is a synthetic analogue of adenosine triphosphate (ATP), which is primarily used in scientific research to study the function of purinergic receptors. This compound is particularly useful in the investigation of P2X receptors, a family of ligand-gated ion channels activated by ATP.
Chemical Structure[edit | edit source]
L-β,γ-Me-ATP is a modified form of ATP where a methyl group is introduced at the β,γ position of the phosphate chain. This modification alters the molecule's interaction with purinergic receptors, making it a valuable tool for distinguishing between different receptor subtypes.
Mechanism of Action[edit | edit source]
L-β,γ-Me-ATP acts as an agonist or antagonist at various purinergic receptors, depending on the receptor subtype and the experimental conditions. It is known to preferentially activate certain P2X receptors, such as P2X1 and P2X3, while having less effect on others. This selectivity is crucial for dissecting the roles of different P2X receptor subtypes in physiological and pathological processes.
Applications in Research[edit | edit source]
L-β,γ-Me-ATP is widely used in pharmacological studies to:
- Characterize the function and distribution of P2X receptors in different tissues.
- Investigate the role of purinergic signaling in pain, inflammation, and neurotransmission.
- Develop new therapeutic agents targeting purinergic receptors for conditions such as chronic pain, neuropathic pain, and urinary bladder disorders.
Experimental Considerations[edit | edit source]
When using L-β,γ-Me-ATP in experiments, researchers must consider factors such as:
- Concentration: The effective concentration of L-β,γ-Me-ATP can vary depending on the receptor subtype and the experimental setup.
- Duration of exposure: Prolonged exposure to L-β,γ-Me-ATP can lead to receptor desensitization, affecting the outcome of the experiment.
- Species differences: The response to L-β,γ-Me-ATP can differ between species, necessitating careful interpretation of results.
Safety and Handling[edit | edit source]
As with all chemical reagents, proper safety protocols should be followed when handling L-β,γ-Me-ATP. This includes wearing appropriate personal protective equipment and working in a well-ventilated area.
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD